Literature DB >> 19484157

Isolated left ventricular noncompaction diagnosed by transthoracic threedimensional echocardiography.

X X Wang1, Z Z Song.   

Abstract

A 55-year-old man was admitted to our hospital because of chest distress, associated with activity. Two-dimensional echocardiography (2DE) demonstrated a suspected trabeculation versus false tendon of the left ventricular apex cordis but not meeting the diagnostic criteria of noncompaction of the ventricular myocardium (NVM). Threedimensional echocardiography (3DE) revealed more prominent trabeculations and deeper intertrabecular recesses of the left ventricular apex, which were consistent with the diagnostic criteria of NVM. In contrast to 2DE, 3DE provides wide, pyramid-shaped datasets that encompass the entire left ventricle. (Neth Heart J 2009;17:208-10.).

Entities:  

Keywords:  Three-dimensional echocardiography; ventricular noncompaction

Year:  2009        PMID: 19484157      PMCID: PMC2688019          DOI: 10.1007/BF03086248

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  12 in total

Review 1.  Isolated noncompaction of the ventricular myocardium: contrast echocardiographic findings and review of the literature.

Authors:  Bon Kwon Koo; Donghoon Choi; Jong-Won Ha; Seok-Min Kang; Namsik Chung; Seung-Yun Cho
Journal:  Echocardiography       Date:  2002-02       Impact factor: 1.724

2.  MRI of subendocardial perfusion deficits in isolated left ventricular noncompaction.

Authors:  Rafaela Soler; Esther Rodríguez; Lorenzo Monserrat; Nemesio Alvarez
Journal:  J Comput Assist Tomogr       Date:  2002 May-Jun       Impact factor: 1.826

3.  Noncompaction of the ventricular myocardium: the use of contrast-enhanced echocardiography in diagnosis.

Authors:  Maureen H Lowery; Jose A Martel; Juan P Zambrano; Alexandre Ferreira; Lourdes Eco; Anthony Gallagher
Journal:  J Am Soc Echocardiogr       Date:  2003-01       Impact factor: 5.251

4.  Natural history and familial characteristics of isolated left ventricular non-compaction.

Authors:  Ross T Murphy; Rajesh Thaman; Juan Gimeno Blanes; Deirdre Ward; Elias Sevdalis; Efi Papra; Anatoli Kiotsekoglou; Anatoli Kiotsekolglou; Maria T Tome; Denis Pellerin; William J McKenna; Perry M Elliott
Journal:  Eur Heart J       Date:  2004-11-30       Impact factor: 29.983

5.  Transthoracic real-time three-dimensional echocardiography in the diagnosis and description of noncompaction of ventricular myocardium.

Authors:  G Hamilton Baker; Naveen L Pereira; Anthony M Hlavacek; Karen Chessa; Girish Shirali
Journal:  Echocardiography       Date:  2006-07       Impact factor: 1.724

6.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

7.  Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background.

Authors:  F Ichida; Y Hamamichi; T Miyawaki; Y Ono; T Kamiya; T Akagi; H Hamada; O Hirose; T Isobe; K Yamada; S Kurotobi; H Mito; T Miyake; Y Murakami; T Nishi; M Shinohara; M Seguchi; S Tashiro; H Tomimatsu
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

Review 8.  Noncompaction of the ventricular myocardium.

Authors:  Y Agmon; H M Connolly; L J Olson; B K Khandheria; J B Seward
Journal:  J Am Soc Echocardiogr       Date:  1999-10       Impact factor: 5.251

9.  Isolated noncompaction of left ventricular myocardium. A study of eight cases.

Authors:  T K Chin; J K Perloff; R G Williams; K Jue; R Mohrmann
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

Review 10.  Clinical applications of transpulmonary contrast echocardiography.

Authors:  M L Main; P A Grayburn
Journal:  Am Heart J       Date:  1999-01       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.